Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Operative Treatment of Mitral Valve Regurgitation Due to Chordal Rupture and/or Papillary Muscle Rupture

건삭 파열 및 유두근 파열로 인한 승모판 판막 폐쇄부전의 외과적 치험

  • 김시호 (동아대학교 의과대학 흉부외과학교실) ;
  • 방정희 (동아대학교 의과대학 흉부외과학교실) ;
  • 우종수 (동아대학교 의과대학 흉부외과학교실)
  • Published : 2004.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: As the rupture of chordae and/or papillary muscle became the main cause of mitral valve regurgitation, mitral reconstructive surgery has a very important role. In this regard, we analyzed the clinical result and postoperative early result of operative treatment performed in our hospital, Material and Method: For this analysis, forty nine patients (male 26, female 23, mean age 49.0$\pm$16.5) who underwent mitral valve operation caused by the rupture of chordae and/or papillary muscle from August 1991 to April 2002 were reviewed. Among forty nine patients, twenty two (44.9%) received mital valve reconstruction and twenty seven (59.2%) received mitral valve replacement. Result: As to the pathological etiology of rupture of mitral and papillary muscle, twenty five cases (51.0%) were nonspecific degeneration, eleven cases (22.4%) were myxomatous degeneration, seven cases (14.3%) were subacute bacterial endocarditis. Three patients suffered mortality after operation (6.1%) and valve replacement was performed again on one patient because of remnant mitral insufficiency after valve reconstruction. The 5-year survival rate after operation for the entire mitral valve regurgitation patients was 81 .4%. We have also compared and analyzed the operation results of a group of patients who underwent valve reconstruction and the other group of patients who underwent valve replacement from thirty six patients who had suffered from mitral valve regurgitation caused by degenerative disease. The mortalities were 0% and 14.3%, respectively and the 5-year survival rates were 90.2% and 64.3%, respectively, but there were no statistical significance. Conclusion: The most common pathological etiology of mitral valve regurgitation caused by rupture of chordae and/or papillary muscle was nonspecific degeneration, In case of degenerative disease is the cause of mitral valve regurgitation, valve reconstruction showed better long-term effects in many respects and better operation results compared to valve replacement.

배경 : 승모판막 폐쇄부전증의 원인 중 건삭이나 유두근 파열이 원인이 되는 예가 증가됨에 따라 승모판막에 대한 수술, 특히 판막 재건술의 임상적 역할이 중요시되고 있다. 이에 본원에서 시행한 승모판막 폐쇄부전증의 수술적 치료에 따른 임상결과 및 술 후 조기 성적을 분석해 보았다. 대상 및 방법: 1991년 8월부터 2002년 4월까지 승모판막 건삭 및 유두근 파열로 인해 본원에서 수술한 승모판막 폐쇄부전증 환자 49명(남 26명, 여 23명, 나이 49.0$\pm$16.5세)을 대상으로 시행하였다. 수술적 방법에 있어서는 22명(44.9%)에서 판막성형술을, 나머지 27명(59.2%)에서는 판막치환술을 시행하였다 결과: 전체수술예에서 승모판막 전엽의 건삭파열은 23예, 후엽의 건삭파열은 31예였으며 전외(Anter-olateral)유두근의 파열이 2예, 후외(Posteromedial)유두근파열이 1예였다 승모판막 건삭 및 유두근 파열의 병리조직학적 원인은 비특이적 변성이 25예(51.0%), 점액성 변성이 11예(22.4%), 아급성세균성 심내막염이 7예(14.3%)였다. 특발성 퇴행성 변성에 의한 건삭 파열의 경우 전엽보다는 후엽에 많았으며 전엽에서는 A3 구역, 후엽에서는 P3 구역에서 빈발하였다. 수술사망은 3명(6.1%)이었으며 1명의 환자에서 판막재건술 시행 후 잔존 승모판막 폐쇄부전으로 인해 판막치환술을 재시행하였다. 전체 승모판막 폐쇄부전환자의 술 후 5년 생존율은 81.4%였다. 승모판막 폐쇄부전의 원인이 퇴행성 병변이었던 환자 36명에 대해서 판막재건술을 시행한 군과 판막치환술을 시행한 군 사이의 수술결과를 비교 분석한 결과, 수술사망률은 각각 0%와 14.3%였고 술 후 5년 생존율은 90.2%와 64.3%로 판막재건술을 시행했던 환자에서 높게 나타났으나 두 군 사이의 통계학적 의의는 보이지 않았다. 결론: 건삭파열 및 유두근 파열로 인한 승모판막 폐쇄 부전의 가장 많은 병리조직학적 원인은 비특이적 변성이었다. 또한 판막 폐쇄 부전의 원인이 승모판막의 퇴행성 병변일 경우에 수술적 방법으로서 승모판막 재건술은 그 장기 성적이 양호하고 수술적 결과가 승모판막 치환술과 비교적 우월한 차이를 보이므로 승모판막 폐쇄 부전의 수술적 치료에 있어서 가장 좋은 방법이라 생각한다.

Keywords

References

  1. N Engl J Med v.335 Clinical outcome of mitral regugitation due to leaflet Ling,L.H.;Enriquez-Sarano,M.;Seward,J.B.(et al.) https://doi.org/10.1056/NEJM199611073351902
  2. Am J Cardiol v.58 Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse Albert,J.;Kolosash,Jr.;Kilman,J.W.;Bush,D.A. https://doi.org/10.1016/0002-9149(86)90352-8
  3. J.Am Coll Cardiol v.5 Primary chordal rupture: Relation to myxomatous valve disease and mitral prolapse Hickey,A.J.;Wilcken,D.E.;Wright,J.S.;Warren,B.A. https://doi.org/10.1016/S0735-1097(85)80346-6
  4. Heart disease: a Textbook of Cardiovascular Medicine.(6th ed.) Brauwald,E.;Zipes,D.P.;Libby,P.
  5. Korean J Thorac Cardiovasc Surg v.34 Comparison of repair and replacement for mitral valve regurgitation Ahn,J.S.;Choi,S.Y.;Park,N.H.(et al.)
  6. Eur J Cardiothrac Surg v.20 A prospective study of change in the quality of life of patients following mitral valve repair and replacement Goldsmith,I.R.;Lip,G.Y.;Patel,R.L. https://doi.org/10.1016/S1010-7940(01)00952-6
  7. J Kor Soc Echocardiogr v.8 The change of cardiac function and morphology after mitral valve repair surgery in mitral valve prolapse with mitral regurgitation Kim,S.Y.;Kim,K.S.;Kim,T.K.;Lee,Y.S.;Cho,G.K.;Son,B.J.
  8. Am J Cardiol v.76 A Predisposing factors for severe mitral regurgitation in idopathic mitral valve prolapse Fukuda,N.;Oki,T.;Lunchi,A. https://doi.org/10.1016/S0002-9149(99)80139-8
  9. Circulation v.48 Angio-graphic-morphologic correlation in patients with severe mitral regurgitation due to prolaspe of the posterior mitral valve leaflet Ranganathan,N.;Silver,M.D.;Robinson,T.I.(et al.) https://doi.org/10.1161/01.CIR.48.3.514
  10. Am Heart J v.132 Relationship between severity of mitral regurgitation and prognosis of mitral valve prolapse: echocar-diographic follow-up study Kim,S.;Kuroda,T.;Nishinaga,M.;Yamasawa,M.;Watanabe,S.;Mitsuhashi,T. https://doi.org/10.1016/S0002-8703(96)90432-9
  11. J Thorac Cardiovasc Surg v.99 Valve repair with Carpentier technique:the second decade Deloche,A.;Jabara,V.A.;Relland,J.Y.M.(et al.)
  12. Circulation v.78 no.SUP.Ⅰ Stability of mitral reconstructive surgery at 10-12 years for predominantly rheumatic valvular disease Duran,C.M.G.;Revuelta,J.M.;Gaite,L.;Alonso,C.;Fleitas,M.G.
  13. Ann Thorac Surg v.58 Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation Akins,C.W.;Hilgenberg,A.D.;Buckley,M.J.(et al.) https://doi.org/10.1016/0003-4975(94)90725-0
  14. J Thorac Cardiovasc Surg v.99 Mitral valve repair results and the decision making process in reconstruction Lessana,A.;Carbone,C.;Romano,M.;Palsky,E.;Quan,Y.H.;eEscorsin,E.
  15. J Heart Valve Dis v.5 Different applications of PTFE valve chordae:surgical technique Zussa,C.
  16. Ann Thorac Surg v.69 Repair of anterior leaflet mitral valve prolapse:chordal replacement versus chordal shortening Phillips,M.R.;Daly,R.C.;Schaff,H.V.;Dearani,J.A.;Mullany,C.J.;Orszulak,T.A.
  17. Korean J Thorac Cardiovasc Surg v.34 Midterm results of mitral valve repair by the new chordae formation technique Lee,J.W.;Lim,H.J.;Jung,S.H.(et al.)
  18. Circulation v.64 no.SUP. Surgical treatment of mitral regurgitation caused by floppy valves:repair versus replacement Yaoub,M.;Halim,M.;Radley-Smith,R.;McKay,R.;Nijveld,A.;Towens,M.
  19. J Thorac Cardiovasc Surg v.107 Long-term results of mitral valve reconstruction for regurgitation of the myxomatous mitral valve Cohn,L.H.;Couper,G.S.;Aranky,S.F.;Rizzo,R.J.;Kinchla,N.M.;Collins,J.J.
  20. Ann Thorac Surg v.68 Restricted posterior leaflet motion after mitral ring annuloplasty Green,G.R.;Dagum,P.;Glasson,J.R.(et al.) https://doi.org/10.1016/S0003-4975(99)01175-3